Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects

AIMS: To evaluate the pharmacology and tolerability of PF-04457845, an orally available fatty acid amide hydrolase-1 (FAAH1) inhibitor, in healthy subjects. METHODS: Double-blind, randomized, placebo-controlled single and multiple rising dose studies and an open-label, randomized, food effect study...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Li, Gai Ling, Winter, Helen, Arends, Rosalin, Jay, Gary W, Le, Vu, Young, Tim, Huggins, John P
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2012
Gaiak:
Pharmacodynamics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3403198/
https://ncbi.nlm.nih.gov/pubmed/22044402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.04137.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak